Synaffix BV
Research - Oss, Noord-Brabant, Netherlands
Synaffix BV Details
Synaffix BV is a biotech company that has established a proprietary, clinical-stage antibody-drug conjugate (ADC) technology platform that delivers best-in-class ADCs (safety and efficacy). Our platform is commercially validated by well over $1.0 billion in technology out-licensing deals with partners including ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio and Kyowa Kirin. These partnerships have rapidly translated Synaffix technology into 11 ADCs currently in development by our partners, where 3 of these are already available in Phase 1 clinical trials.Through the platform, we can rapidly generate best-in-class ADCs for our partners from any antibody and our patent portfolio protects our proprietary processes and any resulting Products through at least 2039. Additionally, Synaffix technology is being deployed to address unmet medical need in several multi-billion-dollar, high growth market segments such as immune cell engagers and targeted gene therapy.
Synaffix BV Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Hosting
Blue Host
Other
Google Maps